GB201909710D0 - Proteins - Google Patents

Proteins

Info

Publication number
GB201909710D0
GB201909710D0 GBGB1909710.4A GB201909710A GB201909710D0 GB 201909710 D0 GB201909710 D0 GB 201909710D0 GB 201909710 A GB201909710 A GB 201909710A GB 201909710 D0 GB201909710 D0 GB 201909710D0
Authority
GB
United Kingdom
Prior art keywords
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1909710.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DEHNS
Universitetet i Oslo
Original Assignee
DEHNS
Universitetet i Oslo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DEHNS, Universitetet i Oslo filed Critical DEHNS
Priority to GBGB1909710.4A priority Critical patent/GB201909710D0/en
Publication of GB201909710D0 publication Critical patent/GB201909710D0/en
Priority to PCT/EP2020/068909 priority patent/WO2021004975A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
GBGB1909710.4A 2019-07-05 2019-07-05 Proteins Ceased GB201909710D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1909710.4A GB201909710D0 (en) 2019-07-05 2019-07-05 Proteins
PCT/EP2020/068909 WO2021004975A1 (en) 2019-07-05 2020-07-03 MODIFIED IgA ANTIBODY PROTEINS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1909710.4A GB201909710D0 (en) 2019-07-05 2019-07-05 Proteins

Publications (1)

Publication Number Publication Date
GB201909710D0 true GB201909710D0 (en) 2019-08-21

Family

ID=67623276

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1909710.4A Ceased GB201909710D0 (en) 2019-07-05 2019-07-05 Proteins

Country Status (2)

Country Link
GB (1) GB201909710D0 (en)
WO (1) WO2021004975A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010457A1 (en) 1989-03-14 1990-09-20 New York University Method of treating hiv infections using immunotoxins
WO2015063611A2 (en) * 2013-11-01 2015-05-07 University Of Oslo Albumin variants and uses thereof

Also Published As

Publication number Publication date
WO2021004975A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
IL288613A (en) Multispecific proteins
DK3737402T3 (en) Modificeret protein
ZA202006252B (en) Yeast proteins
IL288412A (en) Peptides
IL289122A (en) Polypeptides
IL281088A (en) Flt3l-based chimeric proteins
EP4083055A4 (en) Sugar-modified protein
IL291618A (en) Heterodimeric proteins
IL289119A (en) Polypeptides
IL304317A (en) Tgf-beta-rii binding proteins
GB201900732D0 (en) Antibodies
GB2586918B (en) Protein Powder
IL284006A (en) Mitochondria-targeting peptides
EP4076343C0 (en) Retinol-based serum
GB201810052D0 (en) Polypeptide
GB201909710D0 (en) Proteins
GB201913320D0 (en) Novel proteins
GB201904756D0 (en) Novel proteins
IL290019A (en) Melanocyte-regulating peptides
GB201906982D0 (en) Peptides
GB201919286D0 (en) Binding proteins
EP4073971A4 (en) Quasi-colocation configuration
GB201902850D0 (en) Antimicroial peptides
IL291310A (en) Aav-compatible laminin-linker polymerization proteins
GB201918693D0 (en) Peptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)